DCM
IMGN

DAFNA Capital Management’s Immunogen Inc IMGN Stock Holding History

DAFNA Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-193,661
Closed -$5.74M – 85
2023
Q4 		$5.74M Buy
193,661
+110,661
+133% +$2.2M 1.38% 23
2023
Q3 		$1.32M Buy
+83,000
New +$1.38M 0.41% 46

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

DAFNA Capital Management's IMGN Position: Q1 2024 in Review

DAFNA Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 193,661 shares — an estimated $5.74M sold.

DAFNA Capital Management first reported a position in IMGN in Q3 2023 and held it in 2 quarters. The position peaked at $5.74M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • DAFNA Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • DAFNA Capital Management sold 193,661 Immunogen Inc shares in Q1 2024, an estimated $5.74M.
  • DAFNA Capital Management first reported a position in Immunogen Inc in Q3 2023 and held it in 2 quarters.
  • DAFNA Capital Management's Immunogen Inc position peaked at $5.74M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on DAFNA Capital Management's 13F filing for Q1 2024, filed 15 May 2024.